Morepen Laboratories Limited has released a press statement detailing its financial performance for the quarter ending in June, highlighting significant growth in revenue and profits. The company reported a record quarterly revenue increase, with medical device sales surging dramatically compared to the previous year. Profit before tax has doubled quarter on quarter, reflecting strong operational performance and cost management. The press release emphasizes the company's strategic partnership for vaccine production, which is expected to enhance its market position.
Morepen Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2021, titled "Morepen records Highest ever Quarterly Revenue Growth of 50% Medical Devices Sales shoot up by 189%; Profit Before Tax doubles Quarter on Quarter".